Psychiatry Investig Search

CLOSE


Psychiatry Investig > Volume 21(5); 2024 > Article
Wang, Wang, Zhang, Liu, and Fang: Informational Analysis and Prediction of Obsessive-Compulsive Disorder Pathogenesis

Abstract

Objective

We aimed to predict the possible mechanism of obsessive-compulsive disorder (OCD) by integrating and analyzing mRNA sequencing results from two datasets and to provide direction for future studies into the pathogenesis of OCD.

Methods

Two OCD datasets, GSE78104 and GSE60190, were obtained, and the intersection of the two gene sets with differential expression in OCD samples was selected. Kyoto Encyclopedia of Genes and Genomes (KEGG) signal pathway enrichment and Gene Ontology (GO) analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) online analysis website for the genes at the intersection, and the data were mapped using http://www.bioinformatics.com.cn. After genes with p≤0.05 had been screened out, protein-protein interaction (PPI) interaction analysis was conducted using Metascape to screen the key Molecular Complex Detection (MCODE) genes. MCODE genes were then enriched using the KEGG signaling pathway and GO classification.

Results

A total of 3,449 differentially expressed genes (DEGs) were obtained from the GSE78104 and GSE60190 datasets. KEGG, GO, and Gene Set Enrichment Analysis analyses of DEGs showed that the onset of OCD was related to oxidative phosphorylation and other metabolic processes, which may have a similar pathogenesis to other neurodegenerative diseases. Single-gene PPI analysis of SAPAP3 revealed that the mechanism by which SAPAP3 knockout induces OCD may also be caused by affecting oxidative phosphorylation.

Conclusion

The mechanism of SAPAP3 knockout-induced OCD in mice may be due to the oxidative phosphorylation process in the body. Future studies on the neural circuit mechanism of OCD should be conducted.

INTRODUCTION

Obsessive-compulsive disorder (OCD) is a relatively common clinically refractory mental disorder characterized by repetitive invasive thoughts and/or repeated ritual behavior [1]. Patients are aware that it serves no purpose but are unable to get rid of it, negatively impacting their quality of life and social adaptability [2,3]. According to recent data, the prevalence of OCD is increasing, with more than 80 million people worldwide suffering from the disorder, most of whom do not benefit from existing treatments [4]. Its etiology and pathogenesis have been studied for more than half a century. OCD is influenced by both heredity and the environment, with abnormal brain structure and cognitive defects; genetic factors are the primary cause of pathogenesis [5-9]. There are currently few indepth studies on the pathogenesis of OCD.
The main hypothesis of this study was that the molecular signaling pathways associated with OCD are dysfunctional, leading to the expression of symptoms. Our goal was to identify key genes and signaling pathways involved in the pathogenesis of OCD by integrating and analyzing sequencing data from two datasets. These genes and pathways can provide insights into the molecular mechanisms underlying OCD pathogenesis, supporting the development of new treatment strategies.

METHODS

Ethics statement

This study was approved by the human ethics committee of the General Hospital of Ningxia Medical University, and each participant provided written informed consent (ethical approval number: 2020-231).

Sequencing datasets

Sequencing datasets related to human OCD were searched in the PubMed Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/). As there were few datasets related to OCD, the screening condition was determined to include all datasets containing samples with OCD. The source of the sequencing samples was human peripheral blood or brain tissue samples from human autopsy, and the sequencing item was mRNA. Two available datasets, GSE78104 and GSE60190, were obtained by filtering. In the GSE78104 dataset, mRNA sequencing was performed on the peripheral blood of 30 patients with OCD and 30 healthy controls. In the GSE60190 dataset, the brain tissues of 16 patients with OCD and 102 healthy controls were sequentially analyzed. Each dataset measured the differentially expressed genes (DEGs) in OCD.

Intersection of genes from GSE78104 and GSE60190 datasets

The GSE78104 and GSE60190 datasets were downloaded from the GEO database, the difference multiple was set as ≥2, and the DEGs in OCD were screened. The DEGs in these two datasets were intersected to obtain genes with abnormal expression in OCD for subsequent analysis. The Venn mapping tool on the bioinformatics online analysis website (http://www.bioinformatics.com.cn) was used to find intersecting genes.

Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analyses

Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) classification enrichment analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) online analysis site (https://david.ncifcrf.gov/tools.jsp) to determine which signaling pathways the intersecting DEGs were enriched in and the biological processes (BPs) they participated in. First, the DEG list was uploaded to the “Upload” module, and Homo sapiens was chosen as the species for analysis. The website filters unrecognized genes and selects the items to be analyzed. For the analyses, the KEGG pathway, GO cellular component (CC), GO BP, and GO molecular function (MF) projects were selected. After the analysis results had been generated, they were downloaded to the local computer in .txt format to be classified and summarized.

Drawing KEGG signal pathway, GO analysis, and Gene Set Enrichment Analysis diagrams

After classifying and summarizing the downloaded DAVID analysis results, we used a bioinformatics online mapping website (http://www.bioinformatics.com.cn) to visualize the enrichment results for the KEGG signaling pathway, GO classifications, and Gene Set Enrichment Analysis (GSEA) diagrams. The DAVID analysis results were rearranged based on the drawing requirements from the website. The rearranged data were uploaded to the data input module, and the image generation parameters were set. After that, the images were mapped and saved at various resolutions.

Protein-protein interaction correlation network analysis and Molecular Complex Detection gene screening

We used the Metascape online analysis website (https://metascape.org/) to analyze the protein-protein interaction (PPI) association network of different genes and screen the key genes using Molecular Complex Detection (MCODE) to determine whether there was a correlation among the many different genes, whether it was possible to classify them, to identify key genes of different categories, and further refine the signaling pathways in which different genes were located. As the number of differential genes surpassed 3,000, exceeding the analytical capacity of the Metascape website, genes with p-values ≤0.05 among the DEGs were screened for PPI analysis. The selected DEGs were uploaded to the Metascape website, and the species were selected for online analysis. The genes obtained from the MCODE module analysis were downloaded, and KEGG signaling pathway enrichment and GO analyses were repeated to better understand the specific signaling pathways that may influence the onset of OCD, as well as the key genes involved in these signaling pathways.

RESULTS

Initial analysis of genes from the GSE78104 and GSE60190 datasets

First, a volcano map comparing the genes in each dataset was generated (Figure 1). We found that in the GSE78104 dataset, more genes were upregulated in OCD patients, whereas more genes were downregulated in the other dataset.
To identify common DEGs in patients with OCD from both datasets, the data was intersected. After intersection, 3,449 common DEGs were identified (Figure 2).

KEGG analysis of intersected DEGs

KEGG analysis was conducted on intersecting genes, and it was found that they were mainly concentrated in the olfactory transduction-related and herpes simplex virus type 1 infection-related pathways (Figure 3).

GO enrichment analysis of intersecting DEGs

GO enrichment analysis was performed on the intersecting genes from the two datasets (Figure 4). The genes were mainly enriched in alkaloid metabolism, urinary sodium excretion, and lauric acid metabolism processes in the human body. The main CCS enriched by these intersecting genes were the globin-hemoglobin complex, REDOX enzyme complex, and hemoglobin complex. The biological functions of these DEGs were related to the activity of alkane monooxygenase, carbonate dehydrase, and endogenous methyl acetate. This suggests that these DEGs are involved in metabolic processes and hemoglobin production in the human body, and it is possible that patients with OCD exhibit metabolic changes.

PPI network analysis of intersecting DEGs

The KEGG and GO analyses of the DEGs was rather general. To determine whether the DEGs had the characteristics of aggregation distribution and whether they were specifically distributed in different signaling pathways, PPI analysis was conducted on the DEGs. The DEGs were mainly divided into seven interrelated gene clusters, five of which contained more than three genes (Figure 5).

KEGG enrichment analysis of MCODE genes

To determine the distribution of the signaling pathways for the genes in the gene clusters from the PPI analysis, KEGG enrichment analysis was conducted. The analysis of different MCODE genes (Figure 6) showed that the overlapping DEGs were mainly related to neurological diseases, such as Huntington’s disease, Parkinson’s syndrome, and Alzheimer’s disease. The intersecting genes were also associated with oxidative phosphorylation, ubiquitin mediated proteolysis, proteasomes, ribosomes, and other BPs.

GO analysis of MCODE gene groups

GO analysis from the five groups of MCODE genes (Figure 7) revealed that the main BPs involved were lysosomal acidification, cytoplasmic transfer, ribosomal subunit assembly, mast cell degranulation, and ubiquitin-independent proteasome protein degradation. The CC category included genes related to COPI-coated cell vesicles, cell membrane composition, ribosome subunit composition, and proteasome composition. The DEGs from the MFs category included genes related to tau protein binding, NADH coenzyme activity regulation, ribosome structure formation, Fc-γ receptor 1 complex composition, and regulation of endogenous peptidase activity. By summarizing GO enrichment results from different MCODE groups, we concluded that DEGs in patients with OCD were mainly involved in protein synthesis and degradation, and that OCD was related to immunity.

GSEA of GSE78104 and GSE60190 datasets

To explore which signaling pathways were associated with the DEGs in the two datasets, GSEA was performed, and the results are shown in Figure 8. The DEGs in the GSE78104 dataset were mainly related to oxidative phosphorylation, ribosomes, and Parkinson’s disease. The DEGs in the GSE60190 dataset were also related to oxidative phosphorylation and Parkinson’s disease, as well as Alzheimer’s disease. These results suggest that the pathogenesis of OCD may be similar to that of neurodegenerative diseases and provide a basis for further study.

Bioinformatics analysis of the possible causes of OCD caused by SAPAP3 knockout

The SAPAP3 knockout mouse model has been used for studying OCD. However, the mechanism by which SAPAP3 knockout causes compulsive behavior in mice has not been studied in detail. Through PPI analysis of SAPAP3 and GO enrichment analysis of key genes interacting with SAPAP3 (Figure 9), we discovered that genes interacting with SAPAP3 were mainly enriched in the biological function category of phosphatase binding. Previous enrichment of DEGs in OCD also revealed that these genes play a role in the process of oxidative phosphorylation, suggesting that SAPAP3 may affect the metabolic processes of mice with OCD by regulating oxidative phosphorylation.

DISCUSSION

By intersecting two mRNA sequencing datasets of OCD and conducting bioinformatics analysis of genes at the intersection, we discovered that OCD may have a pathogenesis similar to that of other neurological diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases. There are currently few studies on the neural circuit mechanisms of OCD, and the cost of such research is high. Therefore, research on the pathogenesis of existing diseases can be used to guide future research on the neural circuit mechanisms of OCD. At present, research on neurodegenerative diseases such as Alzheimer’s disease is relatively mature, with many related mechanism studies [10-13]; therefore, research on the mechanism of OCD has a high reference value.
Furthermore, data integration analysis revealed that DEGs in patients with OCD were primarily concentrated in oxidative phosphorylation, metabolism, and other related signaling pathways and BPs. This suggests that the onset of OCD may be related to abnormalities in these metabolism-related signaling pathways, and that these metabolic indicators will change in patients with OCD, providing a reference value for the diagnosis and treatment of OCD in the future.
Sapap3 is a protein-coding gene for SAPAP3, also known as DLGAP3. SAPSP3 is the only protein in the SAPAP family that plays a role in the striatum, and its deletion results in abnormal nerve signal transduction [14-16]. SAPAP3 is primarily found in synapses and a component of the postsynaptic dense layer. The SAP90/PSD-95 family of proteins are scaffolding protein centers in the postsynaptic dense region, and they contain three PDZ protein domains, one SH3 domain, and one guanylate kinase domain [17]. SAPAP3 is highly expressed in cholinergic and glutaminergic synapses and involved in the complex assembly of proteins and the regulation of postsynaptic neurotransmitter receptor activity, which primarily occurs at the neuromuscular junction [18]. The PDZ region of the SAPAP3 protein can bind to NMDA receptors and other ion channels [19], and has molecular adaptor activity and scaffold protein binding activity [20]. The guanylate kinase region binds to the SAPAP/GKAP/DAP family of proteins [21].
Many studies have confirmed that SAPAP3 is involved in the molecular organization of synapses and neuronal cell signal transduction, possibly by connecting ion channels and the subsynaptic cytoskeleton and inducing PSD-95/SAP90 enrichment in the plasma membrane [22-24]. Trichotillomania and impulse control disorders are associated with SAPAP3 [25]. Related pathways include PPIs at synapses and chemical intersynaptic transmission. GO annotations associated with Sapap3 included amyloid-beta binding. An important byproduct of this gene is DLGAP2.
In addition, SAPAP3 has been linked to fragile X syndrome, which is characterized by mental retardation and behavioral abnormalities [26]. Most children with fragile X syndrome are hyperactive, inattentive, impulsive, manic, and disruptive. Autism is also more common in children with this disease [27,28].
SAPAP3 knockout mice are recognized as an animal model for the study of OCD. When the Sapap3 gene is knocked out in mice, they show hair plucking behavior, similar to the behavior of forced hand washing in humans and reverse learning disorders, which are important behavioral markers of OCD [15,18,29,30]. SAPAP3 knockout mice are important tools for studying the neural circuit mechanisms of OCD [31,32].
Several studies have reported an association between SAPAP3 and OCD. SAPAP3 mutant mouse models show a significant increase in the postsynaptic density of NR1 and NR2B in the mouse striate, and decreased levels of NR2A, suggesting that SAPAP3 plays a role in the maturation of corticostriatal synaptic function. Brain slices of SAPAP3 mutant mice were observed using electron microscopy, and the thickness of the dense layer of the striatum was reduced. Based on the above results, the structure and function of the cortex-striatum in mice changes after SAPAP3 mutation.
Although SAPAP3 mutations cause obsessive symptoms in mice, the underlying mechanisms are not well understood. Some studies have found that SAPAPs, through their influence on mGluR activity, may act as regulatory molecules to control the threshold for inducing endocannabinoid-mediated synaptic plasticity, which may be an indirect mechanism by which SAPAP3 causes OCD [33]. Another study found that SAPAP3 binds to Neural Abelson-related gene-binding protein 2 (nArgBP2), which regulates excitatory synapse formation by controlling dendritic spinous morphology [34]. Thus, SAPAP3 plays a role in manic, autistic, and obsessive behaviors, and the combination of SAPAP3 and nArgBP2 may affect pathogenesis.
The development of the SAPAP3 knockout mouse model for studying OCD was a key step in the study of the neural circuit mechanisms of OCD. However, there have been few studies on the mechanism of compulsive behavior caused by SAPAP3 knockout in mice. We found through our analysis that genes that interact with SAPAP3 were enriched in the biological function category of phosphatase binding, which was consistent with the DEGs in OCD. These results provide evidence as to why SAPAP3 knockout causes compulsive behavior.
This paper provides valuable insights into the pathogenesis of OCD by identifying potential genes and pathways associated with the development of OCD. These findings may help clinicians better understand the molecular mechanisms of OCD and identify new targets for treatment and prevention strategies. In addition, the identification of key genes and pathways may induce the development of personalized or precision medicine approaches for people with OCD, improving their clinical outcomes.
A limitation of this study is that only existing sequencing data were used to identify signaling pathways and BPs associated with SAPAP3 in patients with OCD, and these predictions have not been validated in animal models. In the future, the SAPAP3 knockout mouse model needs to be customized and used to validate the signaling pathways identified in our analysis.

Notes

Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Author Contributions

Conceptualization: Jianqun Fang. Formal analysis: Doudou Liu. Visualization: Doudou Liu, Manxue Zhang. Writing—original draft: Doudou Liu, Yanrong Wang. Writing—review & editing: all authors.

Funding Statement

The study was funded by the Natural Science Foundation of Ningxia; grant number: 2022AAC02067. The funding source did not play any role in the study design, analysis, and interpretation of data, the writing of the paper, or the decision to submit the article for publication.

ACKNOWLEDGEMENTS

None

Figure 1.
Volcano maps of the GSE78104 and GSE60190 datasets. A: GSE78104 dataset. B: GSE60190 dataset. The horizontal axis represents the change of the gene expression multiple in different samples; the vertical axis represents the statistical significance of the change in gene expression. Padj, P.adjust.
pi-2023-0149f1.jpg
Figure 2.
DEG intersection of the GSE78104 and GSE60190 datasets. After the data of GSE78104 and GSE60190 had been intersected, a total of 3,449 DEGs were identified. DEGs, differentially expressed genes.
pi-2023-0149f2.jpg
Figure 3.
KEGG pathway enrichment results of intersecting genes. The vertical axis represents the pathway name, the horizontal axis represents the ratio of Input frequency/background frequency in the enrichment analysis results, and the dot size represents the number of DEGs. The color corresponds to the p-value in the enrichment analysis results. KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes.
pi-2023-0149f3.jpg
Figure 4.
GO pathway enrichment results of intersecting genes. The horizontal axis represents the GO database categories: BPs in green, CCs in orange, and MFs in blue. The vertical axis represents the enrichment score, which represents the degree of enrichment. GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function.
pi-2023-0149f4.jpg
Figure 5.
PPI analysis of intersecting genes. DEGs were mainly divided into seven interrelated gene clusters (created by https://metascape.org/). PPI, protein-protein interaction; DEGs, differentially expressed genes; MCODE, Molecular Complex Detection.
pi-2023-0149f5.jpg
Figure 6.
KEGG enrichment analysis of MCODE gene groups. The vertical axis represents the pathway name, the horizontal axis represents the ratio of Input frequency/background frequency in the enrichment analysis results, and the dot size represents the number of DEGs. The color corresponds to the p-value in the enrichment analysis results. KEGG, Kyoto Encyclopedia of Genes and Genomes; MCODE, Molecular Complex Detection; DEGs, differentially expressed genes.
pi-2023-0149f6.jpg
Figure 7.
GO enrichment analysis of MCODE gene groups. The horizontal axis represents the GO database categories: BPs in green, CCs in orange, and MFs in blue. The vertical axis represents the enrichment score, which represents the degree of enrichment. GO, Gene Ontology; MCODE, Molecular Complex Detection; BP, biological process; CC, cellular component; MF, molecular function.
pi-2023-0149f7.jpg
Figure 8.
GSEA results of the GSE78104 and GSE60190 datasets. A: GSE78104 dataset. B: GSE60190 dataset. On the horizontal axis, from 0 to 20,000, are all the sequenced gene sets. The top vertical coordinate is the enrichment score. The lower vertical axis represents the association between gene expression and phenotype. KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, Gene Set Enrichment Analysis.
pi-2023-0149f8.jpg
Figure 9.
PPI analysis and GO enrichment analysis of SAPAP3. A: PPI analysis of SAPAP3. B: GO enrichment analysis of SAPAP3. The horizontal axis represents the p-value, and the vertical axis represents the GO database categories. FDR, false discovery rate; PPI, proteinprotein interaction; GO, Gene Ontology.
pi-2023-0149f9.jpg

REFERENCES

1. Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep 2019;21:78
crossref pmid pdf
2. Stein DJ. Obsessive-compulsive disorder. Lancet 2002;360:397-405.
crossref pmid
3. Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet 2009;374:491-499.
crossref pmid
4. Dougherty DD, Brennan BP, Stewart SE, Wilhelm S, Widge AS, Rauch SL. Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry 2018;75:1081-1087.
crossref pmid
5. Kiverstein J, Rietveld E, Slagter HA, Denys D. Obsessive compulsive disorder: a pathology of self-confidence? Trends Cogn Sci 2019;23:369-372.
crossref pmid
6. Leckman JF. New insights into the genetic architecture of obsessive-compulsive disorder: another step along the way. Am J Psychiatry 2022;179:177-179.
crossref pmid
7. Shrinivasa B, Cherian AV, Arumugham SS, Philip BV, Pandian DR, Math SB, et al. Predictors of family accommodation in obsessive compulsive disorder. Asian J Psychiatr 2020;53:102189
crossref pmid
8. Mahjani B, Klei L, Hultman CM, Larsson H, Devlin B, Buxbaum JD, et al. Maternal effects as causes of risk for obsessive-compulsive disorder. Biol Psychiatry 2020;87:1045-1051.
crossref pmid pmc
9. Negreiros J, Belschner L, Best JR, Lin S, Franco Yamin D, Joffres Y, et al. Neurocognitive risk markers in pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 2020;61:605-613.
crossref pmid pdf
10. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. Alzheimer's disease. Lancet 2021;397:1577-1590.
crossref pmid pmc
11. Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer’s disease: towards implementation in clinical practice and trials. Lancet Neurol 2022;21:726-734.
crossref pmid
12. Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives. Mol Neurodegener 2021;16:76
crossref pmid pmc pdf
13. Chami M. Calcium signalling in Alzheimer's disease: from pathophysiological regulation to therapeutic approaches. Cells 2021;10:140
crossref pmid pmc
14. Bienvenu OJ, Wang Y, Shugart YY, Welch JM, Grados MA, Fyer AJ, et al. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet 2009;150B:710-720.
crossref pmid pmc
15. Chen M, Wan Y, Ade K, Ting J, Feng G, Calakos N. Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci 2011;31:9563-9573.
crossref pmid pmc
16. Rasmussen AH, Rasmussen HB, Silahtaroglu A. The DLGAP family: neuronal expression, function and role in brain disorders. Mol Brain 2017;10:43
crossref pmid pmc pdf
17. Wan Y, Ade KK, Caffall Z, Ilcim Ozlu M, Eroglu C, Feng G, et al. Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. Biol Psychiatry 2014;75:623-630.
crossref pmid
18. Xu P, Grueter BA, Britt JK, McDaniel L, Huntington PJ, Hodge R, et al. Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice. Proc Natl Acad Sci U S A 2013;110:10759-10764.
crossref pmid pmc
19. Borschel WF, Murthy SE, Kasperek EM, Popescu GK. NMDA receptor activation requires remodelling of intersubunit contacts within ligand-binding heterodimers. Nat Commun 2011;2:498
crossref pmid pdf
20. Petit CM, Zhang J, Sapienza PJ, Fuentes EJ, Lee AL. Hidden dynamic allostery in a PDZ domain. Proc Natl Acad Sci U S A 2009;106:18249-18254.
crossref pmid pmc
21. Yao I, Hata Y, Hirao K, Deguchi M, Ide N, Takeuchi M, et al. Synamon, a novel neuronal protein interacting with synapse-associated protein 90/postsynaptic density-95-associated protein. J Biol Chem 1999;274:27463-27466.
crossref pmid
22. Gomperts SN. Clustering membrane proteins: it’s all coming together with the PSD-95/SAP90 protein family. Cell 1996;84:659-662.
crossref pmid
23. Niethammer M, Valtschanoff JG, Kapoor TM, Allison DW, Weinberg RJ, Craig AM, et al. CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95/SAP90. Neuron 1998;20:693-707.
crossref pmid
24. Kim E, Cho KO, Rothschild A, Sheng M. Heteromultimerization and NMDA receptor-clustering activity of chapsyn-110, a member of the PSD-95 family of proteins. Neuron 1996;17:103-113.
crossref pmid
25. McElroy SL, Hudson JI, Pope Hg Jr, Keck PE Jr, Aizley HG. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry 1992;149:318-327.
crossref pmid
26. Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr, Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Primers 2017;3:17065
crossref pmid pdf
27. Deng PY, Klyachko VA. Channelopathies in fragile X syndrome. Nat Rev Neurosci 2021;22:275-289.
crossref pmid pmc pdf
28. Kalin NH. Neurodevelopmental and neurodegenerative illnesses: autism, fragile X syndrome, Parkinson’s disease, and dementia. Am J Psychiatry 2022;179:515-518.
crossref pmid
29. Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007;448:894-900.
crossref pmid pmc pdf
30. Zhan Y, Wei J, Liang J, Xu X, He R, Robbins TW, et al. Diagnostic classification for human autism and obsessive-compulsive disorder based on machine learning from a primate genetic model. Am J Psychiatry 2021;178:65-76.
crossref pmid
31. Davis GL, Minerva AR, Lario A, Simmler LD, Rodriguez CI, Gunaydin LA. Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice. Nat Commun 2021;12:6040
crossref pmid pmc pdf
32. Hadjas LC, Schartner MM, Cand J, Creed MC, Pascoli V, Lüscher C, et al. Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice. Neuropsychopharmacology 2020;45:2020-2029.
crossref pmid pmc pdf
33. Wan Y, Feng G, Calakos N. Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J Neurosci 2011;31:16685-16691.
crossref pmid pmc
34. Zhang Y, Wu J, Yan Y, Gu Y, Ma Y, Wang M, et al. SAPAP3 regulates epileptic seizures involving GluN2A in post-synaptic densities. Cell Death Dis 2022;13:437
crossref pmid pmc pdf


ABOUT
AUTHOR INFORMATION
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
Editorial Office
#522, 27, Seochojungang-ro 24-gil, Seocho-gu, Seoul 06601, Korea
Tel: +82-2-717-0892    E-mail: psychiatryinvest@gmail.com                

Copyright © 2024 by Korean Neuropsychiatric Association.

Developed in M2PI

Close layer
prev next